SCHEMBL14927043

SCHEMBL14927043

COc1cc(-c2cc3cc(C)c(C)cc3c(Cl)n2)cc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.42
▸ ACHE P22303 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ ACACA Q13085 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ TDO2 P48775 1/20 0.38
▸ PDGFRB P09619 3/20 0.38
▸ CTDSP1 Q9GZU7 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12072009 0.91 CTDSP1 (0.46) FYNACHEL3MBTL1MEN1KMT2A
SCHEMBL14927078 0.83 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL9986895 0.80 SMN1; SMN2 (0.50) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL14927081 0.77 L3MBTL1 (0.46) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL14927044 0.75 KMT2A (0.40) FYNMEN1KMT2APDGFRBMAPT
SCHEMBL14930629 0.75 RAC1 (0.60) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL9986686 0.74 MEN1 (0.51) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL9986982 0.74 MEN1 (0.51) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL14927045 0.74 PTAFR (0.49) FYNACHEMEN1KMT2AALDH1A1
SCHEMBL128807 0.70 RAC1 (0.46) L3MBTL1MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 FYN 3983/4885ACHE 2854/4885L3MBTL1 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback